Cargando…

Immunogenicity and protective efficacy of DNA vaccine against visceral leishmaniasis in BALB/c mice

The current study was designed to examine the protective efficacy of DNA vaccines based on gp63 and Hsp70 against murine visceral leishmaniasis. Inbred BALB/c mice were immunized subcutaneously twice at an interval of three weeks with pcDNA3.1(+) encoding T cell epitopes of gp63 and Hsp70 individual...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaur, Sukhbir, Kaur, Tejinder, Joshi, Jyoti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Department of Journal of Biomedical Research 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946321/ https://www.ncbi.nlm.nih.gov/pubmed/27533939 http://dx.doi.org/10.7555/JBR.30.20150125

Ejemplares similares

Protective efficacy of Chlorophytum borivilianum root extract against murine visceral leishmaniasis by immunomodulating the host responses
por: Kaur, Rupinder, et al.
Publicado: (2020)

Evaluation of in vitro and in vivo antileishmanial potential of bergenin rich Bergenia ligulata (Wall.) Engl. root extract against visceral leishmaniasis in inbred BALB/c mice through immunomodulation
por: Kaur, Rupinder, et al.
Publicado: (2017)

Evaluation of Nephroprotective and Immunomodulatory Activities of Antioxidants in Combination with Cisplatin against Murine Visceral Leishmaniasis
por: Sharma, Meenakshi, et al.
Publicado: (2012)

Leishmaniasis diagnosis: an update on the use of parasitological, immunological and molecular methods
por: Thakur, Shivani, et al.
Publicado: (2020)

Immunoprophylactic Potential of a Cocktail of Three Low Molecular Weight Antigens of Leishmania donovani along with Various Adjuvants Against Experimental Visceral leishmaniasis
por: KAUR, Harpreet, et al.
Publicado: (2018)

Immunogenicity assay of the Leishmune(®) vaccine against canine visceral leishmaniasis in Brazil
por: Borja-Cabrera, G.P., et al.
Publicado: (2008)

Safety and Efficacy of Prosopis juliflora Leaf Extract as a Potential Treatment against Visceral Leishmaniasis in Balb/c Mice
por: Mutile, Muendo Charity, et al.
Publicado: (2021)

Immunogenicity and protection effects of cationic liposome containing imiquimod adjuvant on leishmaniasis in BALB/c mice
por: Mehravaran, Ahmad, et al.
Publicado: (2019)

Immunogenicity of RSV F DNA Vaccine in BALB/c Mice
por: Eroglu, Erdal, et al.
Publicado: (2016)

Mimotope-Based Vaccines of Leishmania infantum Antigens and Their Protective Efficacy against Visceral Leishmaniasis
por: Costa, Lourena Emanuele, et al.
Publicado: (2014)

Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis
por: Martins, Vivian Tamietti, et al.
Publicado: (2015)

Nucleoside hydrolase DNA vaccine against canine visceral leishmaniasis
por: Borja-Cabrera, GP, et al.
Publicado: (2009)

Immunogenicity and Efficacy of Single Antigen Gp63, Polytope and PolytopeHSP70 DNA Vaccines against Visceral Leishmaniasis in Experimental Mouse Model
por: Sachdeva, Rakhee, et al.
Publicado: (2009)

Development of Vaccines against Visceral Leishmaniasis
por: Evans, Krystal J., et al.
Publicado: (2012)

Polymeric Delivery Systems as a Potential Vaccine against Visceral Leishmaniasis: Formulation Development and Immunogenicity
por: da Silva, João Guilherme Lino, et al.
Publicado: (2023)

Correction: Antigenicity, Immunogenicity and Protective Efficacy of Three Proteins Expressed in the Promastigote and Amastigote Stages of Leishmania infantum against Visceral Leishmaniasis
por: Martins, Vivian Tamietti, et al.
Publicado: (2015)

Immunogenicity of SARS inactivated vaccine in BALB/c mice
por: Xiong, Sheng, et al.
Publicado: (2004)

A defined subunit vaccine that protects against vector-borne visceral leishmaniasis
por: Duthie, Malcolm S., et al.
Publicado: (2017)

Immunogenicity of Multiepitope Vaccine Candidate against Toxoplasma gondii Infection in BALB/c Mice
por: HAJISSA, Khalid, et al.
Publicado: (2018)

Evaluation of a new live recombinant vaccine against cutaneous leishmaniasis in BALB/c mice
por: Salari, Samira, et al.
Publicado: (2020)

Comparison of multiple DNA vaccines for protection against cytomegalovirus infection in BALB/c mice
por: Huang, Chaoyang, et al.
Publicado: (2014)

Efficacy of an Immunotherapy Combining Immunogenic Chimeric Protein Plus Adjuvant and Amphotericin B against Murine Visceral Leishmaniasis
por: Vale, Danniele L., et al.
Publicado: (2023)

Evaluation of synergistic therapeutic effect of shark cartilage extract with artemisinin and glucantime on visceral leishmaniasis in BALB/c mice
por: Molaie, Soheila, et al.
Publicado: (2019)

Tissue-specific transcriptomic changes associated with AmBisome® treatment of BALB/c mice with experimental visceral leishmaniasis
por: Forrester, Sarah, et al.
Publicado: (2019)

Transcriptome Analysis Identifies Immune Markers Related to Visceral Leishmaniasis Establishment in the Experimental Model of BALB/c Mice
por: Agallou, Maria, et al.
Publicado: (2019)

Peptide-based vaccine successfully induces protective immunity against canine visceral leishmaniasis
por: Petitdidier, Elodie, et al.
Publicado: (2019)

Relative immunogenicity and protection potential of candidate Yersinia Pestis antigens against lethal mucosal plague challenge in Balb/C mice
por: Wang, Shixia, et al.
Publicado: (2008)

Evaluation of Leishmania donovani Protein Disulfide Isomerase as a Potential Immunogenic Protein/Vaccine Candidate against Visceral Leishmaniasis
por: Kushawaha, Pramod Kumar, et al.
Publicado: (2012)

LACK Gene’s Immune Response Induced by Cocktail DNA Vaccine with IL-12 Gene Against Cutaneous Leishmaniasis in BALB/c Mice
por: Jorjani, Oghlniaz, et al.
Publicado: (2018)

Assessment of Vaccine-Induced Immunity Against Canine Visceral Leishmaniasis
por: Moreno, Javier
Publicado: (2019)

Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine
por: Borja-Cabrera, Gulnara Patricia, et al.
Publicado: (2004)

Investigation of the antigenicity and protective efficacy of Leishmania promastigote membrane antigens in search of potential diagnostic and vaccine candidates against visceral leishmaniasis
por: Ejazi, Sarfaraz Ahmad, et al.
Publicado: (2020)

The immunogenicity and protective immunity of multi-epitopes DNA prime-protein boost vaccines encoding Amastin-Kmp-11, Kmp11-Gp63 and Amastin-Gp63 against visceral leishmaniasis
por: Zhang, Jianhui, et al.
Publicado: (2020)

Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c mice
por: Danesh-Bahreini, Mohammad Ali, et al.
Publicado: (2011)

The role of ISCOMATRIX bilayer composition to induce a cell mediated immunity and protection against leishmaniasis in BALB/c mice
por: Mehravaran, Ahmad, et al.
Publicado: (2016)

Photodynamic Vaccination of BALB/c Mice for Prophylaxis of Cutaneous Leishmaniasis Caused by Leishmania amazonensis
por: Viana, Sayonara M., et al.
Publicado: (2018)

Leptin regulates Granzyme-A, PD-1 and CTLA-4 expression in T cell to control visceral leishmaniasis in BALB/c Mice
por: Dayakar, Alti, et al.
Publicado: (2017)

Validating Immunomodulatory Responses of r-LdODC Protein and Its Derived HLA-DRB1 Restricted Epitopes against Visceral Leishmaniasis in BALB/c Mice
por: Pandey, Rajkishor, et al.
Publicado: (2022)

Immunogenic properties of empty pcDNA3 plasmid against zoonotic cutaneous leishmaniasis in mice
por: Montakhab-Yeganeh, Hossein, et al.
Publicado: (2022)

A gp63 based vaccine candidate against Visceral Leishmaniasis
por: Sinha, Sukrat, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3pl3bgsd86c0ktfvaj1i880132